Clinical Trial Update: MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating metoclopramide, dexamethasone, or Axoli to prevent or delay chemotherapy-induced nausea and vomiting in moderately emetogenic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Axoli
• DEXAMETHASONE (Dexamethasone)
• Metoclopramide (metoclopramide)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Solid Tumors | Phase 3 | Status: COMPLETED